Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SHAUN S BERGER

Allopathic & Osteopathic Physicians Pediatrics

NPI
1033228838
CMS profile
1189751
Location
SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$159.46

8 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2024 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $159.46 8

By paying entity

PY2024 · entire year · sorted by reported total

Paying entityAmountRecords
Phadia US Inc. $52.63 2
Cranial Technologies, Inc $35.72 3
PFIZER INC. $31.64 1
IRONWOOD PHARMACEUTICALS, INC $22.42 1
GlaxoSmithKline, LLC. $17.05 1

Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SHAUN S BERGER

NPI 1033228838 · CMS profile ID 1189751

Allopathic & Osteopathic Physicians / Pediatrics

SAN DIEGO, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1033228838?year=2024&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SHAUN S BERGER, NPI 1033228838, CMS profile ID 1189751. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1033228838?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). SHAUN S BERGER, NPI 1033228838, CMS profile ID 1189751. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1033228838?year=2024&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
SHAUN S BERGER, NPI 1033228838, CMS profile ID 1189751, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–8 of 8 matching records. This page contains 8 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1033228838?year=2024&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

8 matching records · $159.46 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 8 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–8 of 8.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Cranial Technologies, Inc $15.4108/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1082216700 CMS
Phadia US Inc. $21.7808/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1067586436 CMS
IRONWOOD PHARMACEUTICALS, INC $22.4207/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1153756522 CMS
PFIZER INC. $31.6407/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131780690 CMS
Cranial Technologies, Inc $12.7506/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1082216698 CMS
GlaxoSmithKline, LLC. $17.0504/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116079146 CMS
Phadia US Inc. $30.8503/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1067586434 CMS
Cranial Technologies, Inc $7.5602/07/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1082216696 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $121.98 1
PY2022 $243.55 2
PY2023 $188.64 4
PY2024 $159.46 8
PY2025 $223.45 6

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2021, 2022, 2023, 2024, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $219,980.52 64
PY2024 Principal investigator $163,066.66 24
PY2023 Principal investigator $26,808.70 6
PY2022 Principal investigator $13,574.72 4
PY2021 Principal investigator $65,759.08 6

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

24 records in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $470.00 12/31/2024 Non-covered Recipient Entity
PARADIGM CLINICAL RESEARCH
3110-305-002 Ph3 Pivotal Peds Post Approval - PMR (M21-265) No dispute reported 06/30/2026 1100765953
Principal investigator 1 SANOFI PASTEUR INC. $13,049.60 12/20/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128697026
Principal investigator 1 SANOFI PASTEUR INC. $1,745.10 12/20/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128697028
Principal investigator 1 SANOFI PASTEUR INC. $2,315.60 12/20/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128697030
Principal investigator 1 SANOFI PASTEUR INC. $1,094.80 12/04/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128697024
Principal investigator 1 SANOFI PASTEUR INC. $1,850.00 11/27/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128697036
Principal investigator 1 SANOFI PASTEUR INC. $4,722.02 11/26/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128697034
Principal investigator 1 ModernaTX, Inc. $15,024.00 11/25/2024 Non-covered Recipient Entity
PARADIGM CLINICAL RESEARCH CENTER
A Phase 1, Randomized, Observer-blind, Placebo-controlled, Age De-escalation Study of the Safety, Tolerability, and Immunogenicity of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months No dispute reported 06/30/2026 1147147561
Principal investigator 1 SANOFI PASTEUR INC. $3,536.40 11/20/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128697032
Principal investigator 1 SANOFI PASTEUR INC. $4,741.04 10/28/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128697038
Principal investigator 1 Amgen Inc. $87.00 10/08/2024 Non-covered Recipient Entity
PARADIGM CLINICAL RESEARCH CENTER INC
Ph3 Pediatric CM Study No dispute reported 06/30/2026 1096315111
Principal investigator 1 Amgen Inc. $2,130.24 10/08/2024 Non-covered Recipient Entity
PARADIGM CLINICAL RESEARCH CENTER INC
Phase P3 Pediatric Study EM No dispute reported 06/30/2026 1096315541
Principal investigator 1 SANOFI PASTEUR INC. $1,660.00 10/03/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128697022
Principal investigator 1 PFIZER INC. $5,531.00 09/18/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers INC
A MASTER PHASE 123 PROTOCOL TO INVESTIGATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BIVALENT BNT162B2 RNA BASED VACCINE CANDIDATES IN HEALTHY CHILDREN No dispute reported 06/30/2026 1131013521
Principal investigator 1 PFIZER INC. $6,350.00 06/29/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers INC
A MASTER PHASE 123 PROTOCOL TO INVESTIGATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BIVALENT BNT162B2 RNA BASED VACCINE CANDIDATES IN HEALTHY CHILDREN No dispute reported 06/30/2026 1131068360
Principal investigator 1 SANOFI PASTEUR INC. $15,758.29 06/13/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers,inc
Phase III, Randomized, Single-blind, Placebo-controlled, Multi-center Study to Evaluate Non-interference of Concomitant Administration of Routine Pediatric Vaccines on the Antibody Response of an Investigational Live-attenuated Respiratory Syncytial Virus (RSV) Vaccine in Healthy Infants and Toddlers (CORAL) No dispute reported 06/30/2026 1128696914
Principal investigator 1 Amgen Inc. $48.42 06/10/2024 Non-covered Recipient Entity
PARADIGM CLINICAL RESEARCH
Ph3 Pediatric CM Study No dispute reported 06/30/2026 1096315105
Principal investigator 1 Amgen Inc. $18,070.00 04/20/2024 Non-covered Recipient Entity
PARADIGM CLINICAL RESEARCH CENTER INC
Ph3 Pediatric CM Study No dispute reported 06/30/2026 1096315107
Principal investigator 1 Amgen Inc. $29,355.65 04/20/2024 Non-covered Recipient Entity
PARADIGM CLINICAL RESEARCH CENTER INC
Phase P3 Pediatric Study EM No dispute reported 06/30/2026 1096315537
Principal investigator 1 SANOFI PASTEUR INC. $3,965.00 03/18/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers, Inc
Safety, Immunogenicity, Infectivity, and Dose-Finding Study of an Investigational Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers No dispute reported 06/30/2026 1128702210
Principal investigator 1 Amgen Inc. $10,538.16 02/08/2024 Non-covered Recipient Entity
PARADIGM CLINICAL RESEARCH CENTER INC
Phase P3 Pediatric Study EM No dispute reported 06/30/2026 1096315539
Principal investigator 1 SANOFI PASTEUR INC. $4,416.00 01/24/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers, Inc
Safety, Immunogenicity, Infectivity, and Dose-Finding Study of an Investigational Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers No dispute reported 06/30/2026 1128702204
Principal investigator 1 PFIZER INC. $2,500.00 01/20/2024 Non-covered Recipient Entity
Paradigm Clinical Research Centers INC
A MASTER PHASE 123 PROTOCOL TO INVESTIGATE THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF BIVALENT BNT162B2 RNA BASED VACCINE CANDIDATES IN HEALTHY CHILDREN No dispute reported 06/30/2026 1131108772
Principal investigator 1 Amgen Inc. $14,108.34 01/09/2024 Non-covered Recipient Entity
PARADIGM CLINICAL RESEARCH CENTER INC
Ph3 Pediatric CM Study No dispute reported 06/30/2026 1096315109